title: Tax oncoprotein trans-represses endogenous B-myb promoter activity in human T cells.
abstract: The B-myb gene was identified on the basis of its homology with the protooncogene c-myb, homolog of the avian myeloblastosis virus (AMV) and avian leukemia virus (E26) transforming genes. Several studies using antisense constructs or antisense oligonucleotides as well as overexpression experiments suggest that B-Myb plays an important role in the transition from G(1) to S phase of the cell cycle and that B-Myb expression is cell cycle regulated. We have previously demonstrated that the human T cell lymphotropic virus type 1 (HTLV1) trans-activator Tax is able to repress transcription from c-myb promoter reporter constructs as well as from the endogenous c-myb promoter in human T cells and that this effect is mediated through inhibition of the c-Myb trans-activating functions. Here we report that both HTLV-1 as well as HTLV-2 Tax proteins inhibit c-Myb trans-activation in mouse embryo fibroblasts (MEFs). In addition to c-Myb, B-Myb expression is also markedly downregulated in HTLV-1-transformed cells at both RNA and protein levels. Furthermore, by using a Jurkat T cell line stably transfected with a tax gene driven by a cadmium-inducible promoter (JPX9), we were able to demonstrate that Tax directly represses the endogenous B-myb promoter in T cells. Because c-Myb and B-Myb have been involved in cell cycle progression, our results suggest that Tax, by repressing both c-Myb and B-Myb endogenous promoters, may bypass their requirement for cell cycle progression in HTLV-1-transformed T cells.
authors.affiliation: Division of Basic Sciences, Basic Research Laboratory, NIH, Bethesda, Maryland 20892, USA. cbeben@helix.nih.gov
authors.forename: C
authors.initials: C
authors.lastname: Nicot
authors.forename: R
authors.initials: R
authors.lastname: Opavsky
authors.forename: R
authors.initials: R
authors.lastname: Mahieux
authors.forename: J M
authors.initials: JM
authors.lastname: Johnson
authors.forename: J N
authors.initials: JN
authors.lastname: Brady
authors.forename: L
authors.initials: L
authors.lastname: Wolff
authors.forename: G
authors.initials: G
authors.lastname: Franchini
mesh_terms: D000818:Animals; D018797:Cell Cycle Proteins; D002461:Cell Line, Transformed; D002472:Cell Transformation, Viral; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism; D004622:Embryo, Mammalian / Q000166:cytology; D005347:Fibroblasts; D016356:Gene Products, tax / Q000494:pharmacology*; D015368:Human T-lymphotropic virus 1 / Q000502:physiology*; D015367:Human T-lymphotropic virus 2 / Q000502:physiology*; D006801:Humans; D019169:Jurkat Cells; D051379:Mice; D011401:Promoter Regions, Genetic; D013601:T-Lymphocytes / Q000821:virology*; D015534:Trans-Activators / Q000235:genetics* / Q000378:metabolism; D015533:Transcriptional Activation
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D016356:Gene Products, tax; C064352:MYBL2 protein, human; C499306:Mybl2 protein, mouse; D015534:Trans-Activators